object
determin
incid
risk
factor
clinic
relev
viral
ventilatorassoci
pneumonia
vap
adult
intens
care
unit
icu
design
prospect
observ
studi
set
adult
medic
icu
univers
hospit
patient
consecut
adult
patient
ventil
h
period
includ
regular
season
viral
infect
intervent
tracheobronchi
aspir
upon
enrol
time
vap
suspicion
measur
result
respiratori
specimen
test
cultur
indirect
immunofluoresc
assay
pcr
rtpcr
virolog
assess
patient
follow
icu
discharg
death
one
hundr
thirtynin
patient
includ
upon
enrol
respiratori
viru
detect
tracheobronchi
aspir
patient
incid
vap
defin
accord
clinic
daili
evalu
patient
bacteria
document
case
wherea
case
caus
viral
infect
encount
among
vap
patient
howev
herp
simplex
viru
hsv
infect
detect
respiratori
specimen
vap
conclus
found
high
incid
infect
vap
patient
howev
nosocomi
viral
vap
like
rare
icu
assess
absenc
respiratori
virusinduc
vap
identifi
prospect
cohort
studi
abstract
object
determin
incid
risk
factor
clinic
relev
viral
ventilatorassoci
pneumonia
vap
adult
intens
care
unit
icu
design
prospect
observ
studi
set
adult
medic
icu
univers
hospit
patient
consecut
adult
patient
ventil
h
period
includ
regular
season
viral
infect
intervent
tracheobronchi
aspir
upon
enrol
time
vap
suspicion
measur
result
respiratori
specimen
test
cultur
indirect
immunofluoresc
assay
pcr
rtpcr
virolog
assess
patient
follow
icu
discharg
death
one
hundr
thirtynin
patient
includ
upon
enrol
respiratori
viru
detect
tracheobronchi
aspir
patient
incid
vap
defin
accord
clinic
daili
evalu
patient
bacteria
document
case
wherea
case
caus
viral
infect
encount
among
vap
patient
howev
herp
simplex
viru
hsv
infect
detect
respiratori
specimen
vap
conclus
found
high
incid
infect
vap
patient
howev
nosocomi
viral
vap
like
rare
icu
assess
absenc
respiratori
virusinduc
introduct
ventilatorassoci
pneumonia
vap
lead
caus
nosocomi
infect
critic
ill
patient
prolong
length
stay
hospit
averag
day
per
patient
incid
vap
vari
mortal
rate
rang
moreov
vap
respons
half
antibiot
prescript
icu
howev
pathogen
respons
vap
remain
unknown
case
accord
standard
bacteriolog
procedur
virus
routin
screen
hypothes
proport
vap
may
caus
nosocomi
transmiss
virus
describ
respiratori
virus
never
assess
intub
patient
therefor
undertook
prospect
observ
studi
determin
incid
viral
vap
among
intub
icu
patient
consecut
admit
period
includ
viral
endem
period
identifi
risk
factor
viral
vap
consecut
intub
adult
admit
intens
care
unit
univers
hospit
caen
septemb
may
screen
prospect
studi
virolog
assess
patient
ventil
h
follow
icu
discharg
death
patient
characterist
includ
age
gender
reason
icu
admiss
mechan
ventil
score
diseas
sever
within
first
day
icu
assess
admiss
simplifi
acut
physiolog
score
type
ii
sap
ii
acut
physiolog
chronic
health
evalu
apach
ii
score
admiss
logist
organ
dysfunct
system
lod
concomit
diseas
immunocompromis
statu
defin
human
immunodefici
viru
infect
hiv
neoplasia
innat
immun
deficit
cystic
fibrosi
chronic
use
steroid
immunosuppress
drug
comorbid
diabet
chronic
obstruct
pulmonari
diseas
copd
asthma
cardiovascular
diseas
also
record
admiss
icu
stay
potenti
risk
factor
develop
vap
defin
chastr
fagon
collect
administr
antibiot
antiacid
histamin
receptor
antagonist
sucralf
corticosteroid
curar
sed
drug
vasopressor
comatos
enter
parenter
nutrit
tracheostomi
reintub
nasotrach
intub
presenc
central
venou
urinari
tract
cathet
durat
length
mechan
ventil
addit
mortal
rate
icu
length
icu
stay
record
vap
episod
lod
moment
suspect
vap
diagnosi
outcom
assess
occurr
shock
multipleorgan
failur
acut
respiratori
distress
syndrom
death
also
record
vap
criteria
prospect
defin
occurr
new
persist
radiograph
infiltr
conjunct
two
follow
fever
hypothermia
leukocytosi
l
leukopenia
l
purul
tracheal
aspir
persist
infiltr
defin
infiltr
present
radiograph
least
h
vap
consid
microbiolog
confirm
presenc
clinic
vap
criteria
posit
gram
stain
respiratori
sampl
growth
bacteri
cultur
tracheobronchi
aspir
colonyform
unit
cfu
ml
bal
cfuml
blood
cultur
pleural
sampl
reveal
bacteri
pathogen
absenc
extrapulmonari
focu
tracheobronchi
aspir
obtain
upon
enrol
elig
patient
determin
could
alreadi
infect
virus
time
vap
suspect
first
episod
vap
includ
respiratori
specimen
transport
virolog
laboratori
steril
contain
convent
method
includ
viral
isol
techniqu
cell
indirect
immunofluoresc
assay
ifa
tracheobronchi
aspir
use
monoclon
antibodi
except
rhinoviru
carri
fresh
specimen
detect
parainfluenza
viru
piv
influenza
viru
b
respiratori
syncyti
viru
rsv
adenoviru
adv
rhinoviru
rv
cytomegaloviru
cmv
herp
simplex
viru
hsv
addit
sampl
divid
aliquot
kept
frozen
nucleic
acid
extract
use
commerci
reagent
qiaamp
viral
rna
minikit
qiagen
rna
virus
chelex
procedur
dna
agent
rtpcr
assay
done
sampl
detect
parainfluenza
viru
influenza
viru
b
c
respiratori
syncyti
viru
metapneumoviru
rhinoviru
coronaviru
pcr
assay
adenoviru
cytomegaloviru
chlamydia
pneumonia
mycoplasma
pneumonia
patient
vap
immunosuppress
use
previous
describ
procedur
one
posit
sever
neg
control
includ
infecti
agent
treat
ident
viru
sampl
throughout
baselin
respiratori
specimen
vap
specimen
process
way
pcr
rtpcr
assay
end
studi
period
result
convent
method
viral
isol
routin
perform
depart
virolog
weekli
transmit
clinician
howev
antivir
drug
could
use
studi
period
except
prove
hsv
cmv
infect
immunocompromis
patient
patient
suspect
vap
tracheobronchi
aspir
bronchoalveolar
lavag
bal
product
also
cultur
bacteria
quantit
qualit
data
express
mean
median
rang
percentag
ci
respect
categor
variabl
compar
use
chisquar
test
fischer
exact
test
appropri
quantit
variabl
compar
use
student
ttest
mannwhitney
nonparametr
test
appropri
multivari
analysi
perform
use
stepwis
logist
regress
model
variabl
p
valu
univari
analysi
enter
multivari
analysi
level
signific
set
test
twosid
use
epiinfo
version
epiinfo
cdc
atlanta
ga
data
collect
epiinfo
sa
version
sa
institut
cari
nc
data
analysi
baselin
characterist
incid
risk
factor
vap
among
patient
admit
icu
studi
period
ventil
h
upon
enrol
tracheobronchi
aspir
taken
viral
studi
patient
fail
patient
technic
problem
accord
definit
describ
materi
method
section
patient
develop
vap
ci
icu
stay
specimen
taken
viral
studi
case
shown
fig
baselin
characterist
patient
patient
without
vap
shown
tabl
ninetysix
patient
admit
commun
hospit
admiss
patient
respiratori
disord
pneumonia
acut
copdasthma
exacerb
aspir
pneumonia
pulmonari
edema
independ
risk
factor
vap
adjust
corticosteroid
vasopressor
septic
shock
mof
nasotrach
intub
sedat
h
stress
ulcer
prophylaxi
copd
asthma
odd
ratio
ci
apach
ii
score
odd
ratio
ci
durat
mechan
ventil
odd
ratio
ci
use
parenter
nutrit
odd
ratio
ci
viral
isol
upon
enrol
risk
factor
vap
odd
ratio
ci
upon
enrol
respiratori
viru
detect
tracheobronchi
aspir
patient
ci
thirti
respiratori
disord
icu
admiss
pneumonia
copdasthma
exacerb
aspir
pneumonia
pulmonari
edema
patient
virus
isol
upon
enrol
acquir
hospit
hsv
rhinoviru
via
among
vap
bacteriolog
confirm
case
bacteria
detect
tracheobronchi
aspir
bronchoalveolar
lavag
pseudomona
aeruginosa
methicillinresist
staphylococcu
aureu
common
pathogen
associ
vap
respect
tabl
specimen
viral
studi
posit
case
herp
simplex
viru
type
hsv
isol
cultur
vap
associ
bacteria
case
associ
cmv
case
two
vap
enteroviru
influenza
viru
detect
respiratori
specimen
respect
associ
pseudomona
aeroginosa
hafnia
alvei
respiratori
specimen
neg
bacteria
virus
patient
regardless
techniqu
use
laboratori
detect
viru
ifi
cultur
pcr
tabl
first
time
set
prospect
observ
studi
conduct
determin
incid
viral
vap
among
adult
icu
patient
despit
systemat
screen
admiss
time
vap
use
sensit
virolog
techniqu
viral
detect
case
caus
viral
infect
detect
howev
found
infect
case
vap
studi
one
influenza
viru
one
enteroviru
detect
respiratori
specimen
vap
patient
case
virus
alreadi
detect
upon
enrol
vap
criteria
fulfil
earli
day
intub
respect
sinc
incub
period
rang
day
influenza
viru
day
enteroviru
excret
period
healthi
infect
subject
vari
fig
profil
studi
tba
tracheobronchi
aspir
vap
ventilatorassoci
pneumonia
tabl
baselin
characterist
patient
patient
without
ventilatorassoci
pneumonia
vap
odd
ratio
ci
confid
interv
icu
intens
care
unit
copd
chronic
obstruct
pulmonari
diseas
apach
ii
acut
physiolog
chronic
health
evalu
type
ii
sap
ii
simplifi
acut
physiolog
score
ii
lod
logist
organ
dysfunct
system
ard
acut
respiratori
distress
syndrom
mof
multipl
organ
failur
bpco
bronchopulmonari
chronic
obstruct
day
respect
suspect
could
respons
vap
underscor
import
initi
specimen
screen
viral
detect
diagnosi
viral
vap
previous
describ
viral
hospitalacquir
infect
defin
viral
infect
occur
patient
hospit
least
longer
time
viral
incub
period
knowledg
one
publish
studi
investig
prospect
incid
respiratori
tract
infect
rsv
immunocompet
intub
adult
admit
icu
commun
outbreak
rsv
infect
among
includ
patient
case
rsv
infect
acquir
adult
icu
found
case
transmiss
infect
secret
healthi
infect
personnel
discuss
proxim
adult
icu
pediatr
icu
could
also
explain
high
incid
rsv
nosocomi
infect
report
studi
contrast
studi
also
report
high
incid
infect
vap
group
case
occur
immunocompromis
patient
squamou
cell
carcinoma
infect
associ
posit
pcr
assay
cmv
case
viral
infect
confirm
presenc
tracheobronch
lesion
cytolog
evid
characterist
intranuclear
inclus
posit
hsv
cultur
know
whether
lower
respiratori
tract
infect
clinic
relev
other
case
sinc
studi
design
answer
question
howev
outcom
patient
without
lower
respiratori
tract
infect
differ
recent
report
also
report
interest
preval
posit
tracheobronchi
aspir
virus
intub
adult
admit
icu
detect
viral
infect
admiss
risk
factor
vap
studi
regardless
virus
isol
howev
impact
initi
posit
viral
screen
subsequ
risk
vap
outcom
present
elsewher
main
strength
studi
elig
patient
consecut
enrol
period
includ
viral
endem
period
moreov
result
robust
sinc
firstli
tracheal
aspir
consid
one
appropri
procedur
isol
virus
perform
major
patient
secondli
respiratori
specimen
cultur
test
indirect
immunofluoresc
assay
respiratori
virus
thirdli
respiratori
specimen
vap
group
test
pcr
rtpcr
consid
sensit
method
detect
virus
case
howev
diagnosi
viral
vap
unlik
sinc
vap
microbiolog
confirm
awar
limit
studi
monocent
observ
design
studi
small
number
observ
vap
well
fact
specimen
viral
studi
taken
vap
may
limit
interpret
clinic
relev
data
report
first
studi
prospect
investig
incid
nosocomi
viral
vap
among
adult
icu
patient
consecut
admit
period
includ
viral
endem
period
respiratori
viru
identifi
caus
vap
result
suggest
viral
vap
like
rare
consequ
search
treat
possibl
virus
probabl
pointless
